Assembly Biosciences (ASMB)
(Real Time Quote from BATS)
$19.07 USD
-0.33 (-1.70%)
Updated Aug 5, 2025 10:32 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Assembly Biosciences, Inc. has a market cap of $148.17M, which represents its share price of $19.40 multiplied by its outstanding shares number of 7.64M. As a small-cap company, ASMB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ASMB 19.07 -0.33(-1.70%)
Will ASMB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ASMB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASMB
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates
ASMB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?
BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround
Other News for ASMB
Assembly Biosciences (ASMB) Showcases Promising Herpes Treatment Data
Assembly Biosciences presents Phase 1a data for ABI-5366, ABI-1179
Assembly Biosciences presents Phase 1a data for ABI-5366, ABI-1179
Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & ...
Assembly announces first participant dosed in Phase 1b trial of ABI-1179